OCM
BLACR

Oaktree Capital Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Oaktree Capital Management’s Portfolio BLACR Stock Details BLACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-175,000
Closed -$28.9K – 262
2023
Q1 		$28.9K Buy
+175,000
New +$28.9K ﹤0.01% 295